Signals Research Suite unifies and structures data to be AI-ready. Our automation allows AI and machine-learning tools analyze...

This article discusses how integrating technologies like AI, machine learning, and data analytics can enhance drug development...

Pharmaceutical and biotechnology companies face many changes if the Biosecure Act passes into law. Learn how Revvity Signals...

Revvity Signals was first-to-market with SaaS software and integrates AI to help empower scientists. Read our interview with...

In 2024, Signals ChemDraw, Signals Clinical and Signals Synergy launched. Read how Revvity Signals supports new modalities in...

Revvity Signals handles all software development, allowing researchers to explore new drug therapies. Learn how our cloud-native...

Artificial intelligence (AI) and machine learning (ML) are revolutionizing the cybersecurity space. Learn how Revvity Signals...

Signals DLX can integrate any lab instrument or application with Signals Notebook. Learn how this provides more time for science...

PROTAC technology and TPD research present many opportunities in drug discovery. Learn how Signals Research Suite provides a...